Skip to main content
Fig. 8 | Cell Communication and Signaling

Fig. 8

From: Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

Fig. 8

Kaplan–Meier plots of TAOK3 in different sub-cohorts of clinical breast cancer patients. a The breast cancer patients with only systemic adjuvant chemotherapy (n = 421). b The same population as Fig. 7a but with post progression survival (n = 43). c The patients only with adjuvant endocrine therapy (n = 1873). d The patients who accepted epirubicin monotherapy as neoadjuvant treatment for breast cancer (n = 107)

Back to article page